SKYSTAR BIO-PHARMACEUTICAL CO Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31)
SKYSTAR BIO-PHARMACEUTICAL CO had Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) of $8.11 as of 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExercisePrice · last filed 2013-11-14
- 2013-09-30: Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) $8.11.
- 2013-06-30: Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) $8.11.
- 2012-12-31: Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) $8.11.
| Period end | Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) |
|---|---|
| 2013-09-30 | $8.11 10-Q · filed 2013-11-14 |
| 2013-06-30 | $8.11 10-Q · filed 2013-08-14 |
| 2012-12-31 | $8.11 10-Q · filed 2013-11-14 |